AChR α 3 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of AChR α 3 monoclonal antibodies for research focused on understanding the acetylcholine receptor alpha 3 subunit. AChR α 3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The AChR α 3 subunit functions as a key component of the nicotinic acetylcholine receptor, playing an essential role in neurotransmission and muscle contraction. Within the peripheral nervous system, AChR α 3 has significant implications for various neurological conditions. Research involving AChR α 3 continues to reveal potential therapeutic targets for conditions such as myasthenia gravis and other neuromuscular diseases. Scientists studying neurotransmitter pathways often incorporate AChR α 3 monoclonal antibodies to explore receptor distribution and function. Investigating AChR α 3 expression patterns helps researchers better understand synaptic transmission mechanisms. Current studies focusing on AChR α 3 are uncovering new aspects of neuromuscular junction development and maintenance. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of neuroscience and neurological disease mechanisms.